| Overview |
| bs-19145R |
| MYEOV Polyclonal Antibody |
| WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), ICC |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MYEOV |
| 61-160/313 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 26579 |
| Q96EZ4 |
| Nucleus |
| Myeloma-overexpressed gene protein; MYEOV; MYEOV_HUMAN; OCIM; Oncogene in multiple myeloma. |
| Myeov is a 313 amino acid protein that is overexpressed in a variety of cancers and is thought to play a prominent role in tumor transformation and metastasis. The gene encoding Myeov maps to human chromosome 11, which comprises approximately 4% of human genomic DNA and is considered a gene and disease association dense chromosome. MYEOV2 (myeloma overexpressed 2) is a 57 amino acid protein that exists as two alternatively spliced isoforms and belongs to the MYEOV2 family. MYEOV2 is encoded by a gene that maps to human chromosome 2q37.3. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
| ICC |
1:100-500 |
Powered by Bioz